Stumpo, S.; Carlini, A.; Mantuano, F.; Di Federico, A.; Melotti, B.; Sperandi, F.; Favorito, V.; De Giglio, A.
Efficacy and Safety of TROP-2-Targeting Antibody–Drug Conjugate Treatment in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Pooled Analysis of Reconstructed Patient Data. Cancers 2025, 17, 1750.
https://doi.org/10.3390/cancers17111750
AMA Style
Stumpo S, Carlini A, Mantuano F, Di Federico A, Melotti B, Sperandi F, Favorito V, De Giglio A.
Efficacy and Safety of TROP-2-Targeting Antibody–Drug Conjugate Treatment in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Pooled Analysis of Reconstructed Patient Data. Cancers. 2025; 17(11):1750.
https://doi.org/10.3390/cancers17111750
Chicago/Turabian Style
Stumpo, Sara, Andrea Carlini, Francesco Mantuano, Alessandro Di Federico, Barbara Melotti, Francesca Sperandi, Valentina Favorito, and Andrea De Giglio.
2025. "Efficacy and Safety of TROP-2-Targeting Antibody–Drug Conjugate Treatment in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Pooled Analysis of Reconstructed Patient Data" Cancers 17, no. 11: 1750.
https://doi.org/10.3390/cancers17111750
APA Style
Stumpo, S., Carlini, A., Mantuano, F., Di Federico, A., Melotti, B., Sperandi, F., Favorito, V., & De Giglio, A.
(2025). Efficacy and Safety of TROP-2-Targeting Antibody–Drug Conjugate Treatment in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Pooled Analysis of Reconstructed Patient Data. Cancers, 17(11), 1750.
https://doi.org/10.3390/cancers17111750
